Skip to content

Comparative Analysis of Pruritus with Intrathecal Fentanyl and Buprenorphine as Adjuvants to Bupivacaine Spinal Anesthesia

Incidence, risk factors and pattern of distribution of pruritis in patients receiving intrathecal fentanyl vs intrathecal buprenorphine as an adjuvant to spinal anaesthesia with bupivacaine - a prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/109969
Enrollment
200
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

dr Sampreeta Lakshmi P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 patients undergoing surgeries under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Patient with allergy to opioids preexisting pruritis; preeclampsia; diabetes mellitus

Design outcomes

Primary

MeasureTime frame
1) To estimate the incidence of pruritic with intrathecal fentanyl and buprenorphine 2) To see the pattern of pruritis following intrathecal fentanyl and buprenorphine administration 3) To compare the incidence and pattern of pruitis between fentanyl and buprenorphine. Timepoint: During operative and 1 hour post operative duration

Secondary

MeasureTime frame
to look for risk factors, association and pattern of distribution of pruritus with intrathecal fentanyl and intrathecal buprenorphineTimepoint: during operative and one hour post operative duration

Countries

India

Contacts

Public ContactSampreeta Lakshmi Pradeep
sampreeta1998@gmail.com09940311242

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026